Innovative strategy for diagnosis and treatment of axial spondyloarthritis


DOI: https://dx.doi.org/10.18565/therapy.2022.2.32-37

Dubinina T.V., Krichevskaya O.A.

V.A. Nasonova Research Institute of Rheumatology, Moscow
Abstract. Inflammatory back pain (IBP) is the leading clinical symptom in the onset of axial spondyloarthritis (axSpA). IBP detection makes it possible to recognize patients with axSpA among other patients with chronic back pain. Early diagnosis makes it possible to avoid diagnostic procedures and therapeutic measures that are not necessary, and timely treatment significantly reduces the risk of structural damage and provides long-term preservation of the life quality of patients. The article describes the main approaches to the diagnosis and treatment of axSpA in primary health care performance.

Literature



  1. Эрдес Ш.Ф., Бадокин В.В., Бочкова А.Г. с соавт. О терминологии спондилоартритов. Научно-практическая ревматология. 2015; 6: 657–60. [Erdes Sh.F., Badokin V.V., Bochkova A.G. et al. On the terminology of spondyloarthritis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2015; 6: 657–60 (In Russ.)]. http://dx.doi.org/10.14412/1995-4484-2015-657-660.

  2. Lipton S., Deodhar A. The new ASAS classification criteria for axial and peripheral spondyloarthritis: Promises and pitfalls. Int J Clin Rheumtol. 2012; 7(6): 675–82. http://dx.doi.org/10.2217/ijr.12.61.

  3. Barnett R., Ingram T., Sengupta R. Axial spondyloarthritis 10 years on: Still looking for the lost tribe. Rheumatology (Oxford). 2020; 59(Suppl 4): iv25–iv37. http://dx.doi.org/10.1093/rheumatology/keaa472.

  4. Hayward R.J., Machado P.M. Classification criteria in axial spondyloarthritis: What have we learned; Where are we going? Rheum Dis Clin North Am. 2020; 46(2): 259–74. http://dx.doi.org/10.1016/j.rdc.2020.01.008.

  5. van der Heijde D., Ramiro S., Landewe R. et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017; 76(6): 978–91. http://dx.doi.org/10.1136/annrheumdis-2016-210770.

  6. Fatoye F., Gebrye T., Odeyemi I. Real-world incidence and prevalence of low back pain using routinely collected data. Rheumatol Int. 2019; 39(4): 619–26. http://dx.doi.org/10.1007/s00296-019-04273-0.

  7. Delitto A., George S.Z., Van Dillen L. et al. Orthopaedic section of the American Physical Therapy Association. Low back pain. J Orthop Sports Phys Ther. 2012; 42(4): A1–57. http://dx.doi.org/10.2519/jospt.2012.42.4.A1.

  8. Sieper J., Rudwaleit M. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis. 2005; 64(5): 659–63. http://dx.doi.org/10.1136/ard.2004.028753.

  9. Magrey M.N., Danve A.S., Ermann J., Walsh J.A. Recognizing axial spondyloarthritis: A guide for primary care. Mayo Clin Proc. 2020; 95(11): 2499–508. http://dx.doi.org/10.1016/j.mayocp.2020.02.007.

  10. Sieper J., van der Heijde D., Landewe R. et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann Rheum Dis. 2009; 68(6): 784–88. http://dx.doi.org/10.1136/ard.2008.101501.

  11. Дубинина Т.В. Воспалительная боль в спине: особенности клинических проявлений и диагностики. Доктор.Ру. 2013; 2: 56–59. [Dubinina T.V. Inflammatory back pain: features of clinical manifestations and diagnosis. Doctor.Ru. 2013; 2: 56–59 (In Russ.)].

  12. Kavadichanda C.G., Geng J., Bulusu S.N. et al. Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 connection. Front Immunol. 2021; 12: 601518. http://dx.doi.org/10.3389/fimmu.2021.601518.

  13. Oliveira C.B., Maher C.G., Pinto R.Z. et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: An updated overview. Eur Spine J. 2018; 27(11): 2791–803. http://dx.doi.org/10.1007/s00586-018-5673-2.

  14. Смирнов А.В., Эрдес Ш.Ф. Оптимизация рентгенодиагностики анкилозирующего спондилита в клинической практике – значимость обзорного снимка таза. Научно-практическая ревматология. 2015; 2: 175–181. [Smirnov A.V., Erdes Sh.F. Optimization of X-ray diagnosis of ankylosing spondylitis in clinical practice: importance of a plain X-ray film of the pelvis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2015; 2: 175–181 (In Russ.)]. http://dx.doi.org/10.14412/1995-4484-2015-175-181.

  15. Эрдес Ш.Ф., Смирнов А.В. Технология диагностики воспалительных изменений скелета при анкилозирующем спондилите по данным магнитно-резонансной томографии. Научно-практическая ревматология. 2019; 6: 678–84. [Erdes Sh.F., Smirnov A.V. Diagnostic technology for inflammatory changes in the skeleton with ankylosing spondylitis according to magnetic resonance imaging. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2019; 6: 678–84 (In Russ.)]. http://dx.doi.org/10.14412/1995-4484-2019-678-684.

  16. Rudwaleit M., van der Heijde D., Landewe R. et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009; 68(6): 777–83. http://dx.doi.org/10.1136/ard.2009.108233.

  17. Deodhar A., Mease P.J., Reveille J.D. et al. Frequency of axial spondyloarthritis diagnosis among patients seen by US rheumatologists for evaluation of chronic back pain. Arthritis Rheumatol. 2016; 68(7): 1669–76. http://dx.doi.org/10.1002/art.39612.

  18. Sieper J., Srinivasan S., Zamani O. et al. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Ann Rheum Dis. 2013; 72(10): 1621–27. http://dx.doi.org/10.1136/annrheumdis-2012-201777.

  19. Мясоутова Л.И., Лапшина С.А., Васильев А.Г., Салихов И.Г. Диагностика и клиническая характеристика анкилозирующего спондилита по данным Городского ревматологического центра г. Казани. Научно-практическая ревматология. 2012; 1: 38–41. [Myasoutova L.I., Lapshina S.A., Vasilyev A.G., Salikhov I.G. The diagnosis and clinical characteristics of ankylosing spondylitis according to the data of the Kazan city rheumatology center. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012; 1: 38–41 (In Russ.)]. http://dx.doi.org/10.14412/1995-4484-2012-502.

  20. van der Heijde D., Ramiro S., Landewe R. et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017; 76(6): 978–91. http://dx.doi.org/10.1136/annrheumdis-2016-210770.

  21. Zochling J., van der Heijde D., Burgos-Vargas R. et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006; 65(4): 442–52. http://dx.doi.org/10.1136/ard.2005.041137.

  22. Дубинина Т.В., Подряднова М.В., Красненко С.О., Эрдес Ш.Ф. Лечебная физкультура при анкилозирующем спондилите: рекомендации и реальность. Научно-практическая ревматология. 2014; 2: 187–191. [Dubinina T.V., Podryadnova M.V., Krasnenko S.O., Erdes Sh.F. Therapeutic exercise for patients with ankylosing spondylitis: recommendations and reality. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014; 2: 187–191 (In Russ.)]. http://dx.doi.org/10.14412/1995-4484-2014-187-191.

  23. Braun A., Saracbasi E., Grifka J. et al. Identifying patients with axial spondyloarthritis in primary care: How useful are items indicative of inflammatory back pain? Ann Rheum Dis. 2011; 70(10): 1782–87. http://dx.doi.org/10.1136/ard.2011.151167.

  24. Ward M.M., Deodhar A., Gensler L.S. et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019; 71(10): 1599–613. http://dx.doi.org/10.1002/art.41042.

  25. Каратеев А.Е., Эрдес Ш.Ф. Применение нестероидных противовоспалительных препаратов при анкилозирующем спондилите: долго и упорно! Терапевтический архив. 2014; 11: 123–127. [Karateev A.E., Erdes Sh.F. Use of nonsteroidal anti-inflammatory drugs in case of ankylosing spondylitis: long and persistently! Terapevticheskiy arkhiv = Therapeutic Archive. 2014; 11: 123–127 (In Russ.)].

  26. Гайдукова И.З., Ребров А.П., Лапшина С.А. с соавт. Применение нестероидных противовоспалительных препаратов и генно-инженерных биологических препаратов для лечения аксиальных спондилоартритов. Рекомендации Экспертной группы по изучению спондилоартритов при Общероссийской общественной организации «Ассоциация ревматологов России». Научно-практическая ревматология. 2017; 5: 474–484. [Gaidukova I.Z., Rebrov A.P., Lapshina S.A. et al. Use of nonsteroidal anti-inflammatory drugs and biological agents for the treatment of axial spondyloarthritides. Recommendations of the Spondyloarthritis Study Group of Experts, All-Russian Public Organization «The Association of Rheumatology of Russia». Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2017; 5: 474–484 (In Russ.)]. http://dx.doi.org/10.14412/1995-4484-2017-474-484.


About the Autors


Tatiana V. Dubinina, PhD, head of the Laboratory of axial spondyloarthritis, V.A. Nasonova Research Institute of Rheumatology. Address: 115522, Moscow, 34A Kashirskoe Highway. E-mail: tatiana-dubinina@mail.ru.
ORCID: https://orcid.org/0000-0002-1771-6246
Olga A. Krichevskaya, PhD, researcher of the Laboratory of axial spondyloarthritis, V.A. Nasonova Research Institute of Rheumatology. Address: 115522, Moscow, 34A Kashirskoe Highway. E-mail: o.krichevskaya@mail.ru.
ORCID: https://orcid.org/0000-0002-1109-9865


Similar Articles


Бионика Медиа